Abstract Number: 1127 • 2013 ACR/ARHP Annual Meeting
Semiquantitative MRI Features Of Knee Osteoarthritis Show Compartment-Specific Relationships With Quantitative Cartilage Thickness Loss: The Multicenter Osteoarthritis Study
Background/Purpose: Structural progression of knee OA has been associated with several radiographic and MRI-measured pathological features of OA, including malalignment, meniscal pathology and bone marrow…Abstract Number: 1129 • 2013 ACR/ARHP Annual Meeting
Development and Validation Of a Rapid Knee Cartilage Quantification Method
Background/Purpose: Cartilage morphometry on magnetic resonance images (MRIs) may become an acceptable outcome measure for clinical trials among patients with knee osteoarthritis (OA). However, obtaining…Abstract Number: 1130 • 2013 ACR/ARHP Annual Meeting
Change In Knee Osteophyte Volume By Semi-Automated Method In Knee Osteoarthritis Over Four Years Using 3T DESS 3D MRI
Background/Purpose: The development and growth of osteophytes are considered a radiographic surrogate for osteoarthritis (OA) at the knee. Methods to determine osteophyte burden are largely…Abstract Number: 1131 • 2013 ACR/ARHP Annual Meeting
Peri-Articular Fractal Signature Analysis and Bone Mineral Density Measure Different Aspects Of Bone: Cross-Sectional Data From The Osteoarthritis Initiative
Background/Purpose: Peri-articular fractal signature analysis (FSA) and bone mineral density (paBMD) are potentially cost-effective prognostic imaging markers for osteoarthritis (OA) progression. While we know that…Abstract Number: 1101 • 2013 ACR/ARHP Annual Meeting
Neuromuscular Taping On Patients With Fibromyalgia May Be a Useful Tool To Relief Muscular Pain
Background/Purpose: Fibromyalgia (FMS) is an illness characterized by an anomalous perception of the painful stimuli that are supposed to be attributable to a combination of…Abstract Number: 1103 • 2013 ACR/ARHP Annual Meeting
Brain Derived Neurotrophic Factor Is Elevated In Patients With Rheumatoid Arthritis and Secondary Fibromyalgia
Background/Purpose: Secondary Fibromyalgia is seen in 15% of patients with rheumatoid arthritis (RA). Neurotrophins are elevated in patients with active arthritis and BDNF is elevated…Abstract Number: 1092 • 2013 ACR/ARHP Annual Meeting
Low Dose Naltrexone In The Treatment Of Fibromyalgia
Background/Purpose: Fibromyalgia is a chronic pain disorder characterized by diffuse musculoskeletal pain, fatigue, sleepdisturbance and cognitive impairment. A significant number of fibromyalgia patients do not…Abstract Number: 1093 • 2013 ACR/ARHP Annual Meeting
SPA Therapy In The Treatment Of Chronic Shoulder PAIN Due To Rotator Cuff Tendinopathy: Rotatherm, A Large Randomized Multicentre Trial
Background/Purpose: To determine whether spa therapy has a beneficial effect on pain and disability in the management of shoulder pain due to chronic rotator cuff…Abstract Number: 1094 • 2013 ACR/ARHP Annual Meeting
Hyperbaric Oxygen Ameliorates Fibromyalgia Symptoms and Functional Impairment – A Randomized Prospective Trial
Background/Purpose: Fibromyalgia Syndrome (FMS), considered to represent a prototype of central nervous system sensitization, is a common condition characterized by chronic widespread pain and diffuse…Abstract Number: 1095 • 2013 ACR/ARHP Annual Meeting
Pooled Safety Data From Randomized, Controlled Trials Of Diclofenac Sodium Topical Gel 1% In Subjects With Acute Pain
Background/Purpose: Diclofenac sodium topical gel (DSG) 1% is clinically proven to be effective and well-tolerated for treatment of osteoarthritis pain and could be appropriate to…Abstract Number: 1096 • 2013 ACR/ARHP Annual Meeting
Is Vitamin D Deficiency a Risk Factor For The Development Of Statin Induced Myalgia, In Patients Treated With Statin?
Background/Purpose: Vitamin D deficiency has become pandemic in the industrializing societies. Recently, the role of vitamin D deficiency in the development of statin myopathy has…Abstract Number: 1097 • 2013 ACR/ARHP Annual Meeting
A Potential Use Of NeurotropinTM, a Novel Neuro-Modulating Medication, For The Treatment Of Chronic Pain and Fibromyalgia
Background/Purpose: To date, no established treatment for chronic pain including fibromyalgia has been specified in Japan. Neurotropin, a non-protein extract isolated from the inflamed cutaneous…Abstract Number: 1098 • 2013 ACR/ARHP Annual Meeting
Safety and Efficacy Of Influenza Vaccination In Patients Suffering From Fibromyalgia
Background/Purpose: Fibromyalgia syndrome (FMS) is considered to result from exposure of a genetically susceptible individual to various "triggers" including physical trauma, stress etc. Viral infections…Abstract Number: 1099 • 2013 ACR/ARHP Annual Meeting
IgG Autoantibodies Against p29ING4 In Early-Stage Type I Complex Regional Pain Syndrome (CRPS) and In Other Inflammatory Diseases Involving The Joints
Background/Purpose: Complex regional pain syndrome (CRPS, a.k.a. RSD) usually occurs after limb injury, especially fractures of the distal radius and elective hand surgery. Recent research…Abstract Number: 1100 • 2013 ACR/ARHP Annual Meeting
Relationship Between Body Mass Index, Fat Mass and Muscle Mass Withmusculoskeletal Pain In Community Residents
Background/Purpose: The association between parameters related to obesity likefat mass,fat/muscle mass ratio and metabolic syndrome andmusculoskeletal pain has scarcily been assessed. The objective of thepresent…